← Leaderboards
Maria Mudryj
Va Northern California Health Care Sys
$0
Attributed
$0
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2011–20$1$1$1$0$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
VA$0 · 2
By mechanism
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Va Northern California Health Care Sys
Same institution · by research overlap
- Joseph M Tuscano$91,254
Others in their field
Top investigators on “Veterans”
- David R. Weir · University Of Michigan At Ann Arbor$296,295,927
- Charles A Coltman · Southwest Oncology Group$122,561,996
- Jennifer A Pietenpol · Vanderbilt University$60,636,894
- Fred M Gordin · Social And Scientific Systems, Inc.$59,139,975
- Adrian Hernandez · Duke University$50,769,596
- Michael W. Konstan · Case Western Reserve University$48,783,827
Research focus
VeteransTumor-DerivedTumorigenesisMorbidity - Disease RateTissuesSurvival RateDiagnosisOverexpressionEtiologyMediatingProteinsProtein IsoformsAndrogensSmall Interfering RnaApoptosisCell LineAblationCellsBaseDisease ProgressionMaleMalignant Neoplasm Of ProstateProstatic NeoplasmsCancer Cell
Grant awards (8)
Defining the role of the androgen receptor low molecular weight isoforms in bladder cancer$0
I01 · FY2020 · VA · contact PI
Defining the role of the androgen receptor low molecular weight isoforms in bladder cancer$0
I01 · FY2019 · VA · contact PI
Defining the role of the androgen receptor low molecular weight isoforms in bladder cancer$0
I01 · FY2018 · VA · contact PI
Defining the role of the androgen receptor low molecular weight isoforms in bladder cancer$0
I01 · FY2017 · VA · contact PI
Modeling E2F3 isoform specificity in prostate cancer$0
I01 · FY2014 · VA · contact PI
Modeling E2F3 isoform specificity in prostate cancer$0
I01 · FY2013 · VA · contact PI
Modeling E2F3 isoform specificity in prostate cancer$0
I01 · FY2012 · VA · contact PI
Modeling E2F3 isoform specificity in prostate cancer$0
I01 · FY2011 · VA · contact PI